ACE2 and viral infectious disease: On the other hand, clinical-grade recombinant human ACE2 (rhACE2), a type of exogenous soluble form of ACE2, binds to SARS-COV-2 in ﻿engineered human tissues and inhibits virus infection (Monteil et al., 2020).